{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:14Z","timestamp":1786120334504,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/ajp.0b013e3182290fae","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T19:02:46Z","timestamp":1317754966000},"page":"268-272","source":"Crossref","is-referenced-by-count":5,"title":["Bisphosphonates for Pain Management in Children With Benign Cartilage Tumors"],"prefix":"10.1097","volume":"28","author":[{"given":"Mark J.","family":"Winston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarak","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Jarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri S.","family":"Alon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-12-20210204","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1586\/14737159.2.5.461","article-title":"Diagnosis and prognosis of chondrosarcoma of bone.","volume":"2","author":"Rozeman","year":"2002","journal-title":"Expert Rev Mol Diagn"},{"key":"R4-12-20210204","first-page":"834","article-title":"Chondrosarcoma secondary to multiple cartilage diseases: study of 29 clinical cases and review of the literature.","volume":"85","author":"Schaison","year":"1999","journal-title":"Rev Chir Orthop Reparatrice Appar Mot"},{"key":"R5-12-20210204","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2106\/00004623-198769020-00016","article-title":"The malignant potential of enchondromatosis.","volume":"69","author":"Schwartz","year":"1987","journal-title":"J Bone Joint Surg (Am)"},{"key":"R6-12-20210204","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1172-1-37","article-title":"Ollier disease.","volume":"1","author":"Silve","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"R7-12-20210204","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2106\/00004623-199407000-00005","article-title":"The natural history of hereditary multiple exostoses.","volume":"76","author":"Schmale","year":"1994","journal-title":"J Bone and Joint Surg (Am)"},{"key":"R8-12-20210204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.berh.2007.12.004","article-title":"Hereditary multiple exostoses and enchondromatosis.","volume":"22","author":"Pannier","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R9-12-20210204","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-3-3","article-title":"Multiple osteochondromas.","volume":"3","author":"Bovee","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"R10-12-20210204","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5435\/00124635-200503000-00004","article-title":"Manifestations of hereditary multiple exostoses.","volume":"13","author":"Stieber","year":"2005","journal-title":"J Am Acad Orthop Surg"},{"key":"R11-12-20210204","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00431-003-1298-4","article-title":"The role of bisphosphonates in diseases of childhood.","volume":"162","author":"Srivastava","year":"2003","journal-title":"Eur J Pediatr"},{"key":"R16-12-20210204","first-page":"929","article-title":"Pamidronate treatment in bone fibrous dysplasia in children and adults with McCune-Albright syndrome.","volume":"15","author":"Matarazzo","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R17-12-20210204","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00467-006-0306-0","article-title":"Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children.","volume":"22","author":"Waterhouse","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"R18-12-20210204","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(94)90069-8","article-title":"Long-term effects of intravenous pamidronate in fibrous dysplasia of bone.","volume":"343","author":"Liens","year":"1994","journal-title":"Lancet"},{"key":"R19-12-20210204","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF03044679","article-title":"Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright Syndrome.","volume":"93","author":"Pfeilschifter","year":"1998","journal-title":"Med Klin (Munich)"},{"key":"R20-12-20210204","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functional outcome with olpadronate in children with OI: a 2-year randomised placebo-controlled study.","volume":"363","author":"Sakkers","year":"2004","journal-title":"Lancet"},{"key":"R21-12-20210204","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV OI confirms vertebral gains but not short-term functional improvement.","volume":"20","author":"Letocha","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R22-12-20210204","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","article-title":"Intravenous neridronate in children with OI: a randomized controlled study.","volume":"20","author":"Gatti","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R23-12-20210204","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S8756-3282(03)00229-1","article-title":"Long-term analgesic effect of clodronate in rodents.","volume":"33","author":"Bonabello","year":"2003","journal-title":"Bone"},{"key":"R24-12-20210204","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0304-3959(00)00447-4","article-title":"Analgesic effect of bisphosphonates in mice.","volume":"91","author":"Bonabello","year":"2001","journal-title":"Pain"},{"key":"R25-12-20210204","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2006.03.015","article-title":"Antiallodynic effect of etidronate, a bisphosphonate, in rats with adjuvant-induced arthritis: involvement of ATP-sensitive K channels.","volume":"51","author":"Kawabata","year":"2006","journal-title":"Neuropharmacology"},{"key":"R26-12-20210204","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejpain.2007.06.005","article-title":"Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.","volume":"12","author":"Bianchi","year":"2008","journal-title":"Eur J Pain"},{"key":"R27-12-20210204","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2008.05.011","article-title":"Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X(23) receptor function and exerts an analgesic effect in pain models.","volume":"589","author":"Kakimoto","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R29-12-20210204","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/01241398-199509000-00004","article-title":"Proximal fibular osteochondroma with associated peroneal nerve palsy: a review of six cases.","volume":"15","author":"Cardelia","year":"1995","journal-title":"J Pediatr Orthop"},{"key":"R30-12-20210204","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00003086-199110000-00035","article-title":"Fracture through the stalk of pedunculated osteochondromas: a report of three cases.","volume":"271","author":"Davids","year":"1991","journal-title":"Clin Orthop"},{"key":"R31-12-20210204","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0885-3924(03)00201-X","article-title":"Treatment of chronic mechanical spinal pain with intravenous pamidronate: a review of medical records.","volume":"26","author":"Pappagallo","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"R32-12-20210204","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosisosteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"R33-12-20210204","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","article-title":"Bisphosphonate-induced osteopetrosis.","volume":"349","author":"Whyte","year":"2003","journal-title":"N Engl J Med"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002508-201203000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:30:58Z","timestamp":1786048258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002508-201203000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ajp.0b013e3182290fae","relation":{},"ISSN":["0749-8047"],"issn-type":[{"value":"0749-8047","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}